Clinical Trials news from FierceHealthcare
News
Feds indict Synthes over off-label promotions
In recent years, orthopedic product maker Synthes Inc. chose a carefully-selected panel of surgeons and paid for them to attend training sessions on its new bone-mending cement. The cement, Norian... Read more...
Stryker faces two new investigations
Devicemaker Stryker Corp. has been targeted by two investigations, one looking at its relationship with doctors, and the other related to compliance issues regarding one of its products. For one... Read more...
Women, minority groups concerned over 'comparative effectiveness'
Women and minorities are up in arms over how some of the money in the recently signed economic stimulus package will be used. According to the Kaiser Network, and first reported by The New York... Read more...
FDA slammed by HHS OIG for lax conflict-of-interest oversight
A new report from the HHS inspector general's office comes down hard on the FDA, arguing that the agency isn't doing enough to make sure clinical-trial sponsors stay on top of their researchers'... Read more...
Comparative effectiveness institute may lead to more pragmatic studies
What will it mean if advocates succeed in their lobbying for a Institute for Comparative Effectiveness Research? Aside from straightforward comparative effectiveness research, it's also likely to... Read more...
Boy wins right to take experimental drug
While the lawsuit was not intended to change the rules regarding clinical trials generally, observers are wondering whether a recent case may indeed change them for patients who, drugmakers say,... Read more...
Suit challenges biotech firm over last-chance drug
In another case challenging the limits of "compassionate use" for drugs not approved by the FDA, the mother of a gravely-ill teenager has filed a lawsuit demanding access to an experimental drug. The... Read more...
Merck drug, suicide linked?
Is there a possible link between the Merck allergy and asthma drug Singulair and suicidal tendencies? The Food and Drug Administration (FDA) is looking into the possibility by "reviewing a handful of... Read more...
Study: Clinical trials cut mortality rates at hospitals
Mortality rates at 494 hospitals around the country that participated in clinical trials for acute coronary syndrome declined, according to Modern Healthcare. Of 174,062 patients treated, only 3.5... Read more...
